Prostate MRI with AI support for cancer detection
Part of Cancer clinical trials.
This study tests whether artificial intelligence can help doctors read prostate MRI scans more accurately, which may improve cancer detection and treatment guidance. It aims to see if AI can assist in identifying suspicious areas without needing a biopsy first.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older
- You are being referred because a doctor suspects you might have prostate cancer
- Your PSA blood test result is 20 ng/mL or lower
- You have not had a prostate biopsy before
- You have never had a prostate MRI that was reviewed by a doctor for your care
- You have no metal implants (like a hip or pelvic replacement) or other reasons you cannot have an MRI
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This trial tests whether an AI program can better spot aggressive prostate cancer on MRI scans, which may help guide treatment decisions. Participation involves having an MRI and possibly a biopsy, and your scan will be analyzed by the software.
This trial studies how AI might improve the process of prostate biopsies for people who have had an MRI. It may help if you are scheduled for a biopsy and have not been treated for prostate cancer before.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
Hear when a new Prostate CA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.